Evidence map›Paper›PMID 34432828›Full record

ArticlePloS one2021

Inflammatory pathways amongst people living with HIV in Malawi differ according to socioeconomic status.

Christine Kelly, Willard Tinago, Dagmar Alber, Patricia Hunter, Natasha Luckhurst, Jake Connolly, Francesca Arrigoni, Alejandro Garcia Abner, Raphael Kamn'gona, Irene Sheha and 8 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01825031 (Reduction of Early mortALITY in HIV-infected African Adults and Children Starting Antiretroviral Therapy), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01825031 phase3completednot on this map

Reduction of Early mortALITY in HIV-infected African Adults and Children Starting Antiretroviral Therapy: a Randomised Controlled Trial

TypeinterventionalSponsorAnna Griffiths, MRCRan2013 to 2016Enrolled1,805ConditionsHuman Immunodeficiency VirusArmsRaltegravir, Fluconazole, Azithromycin, Albendazole, Isoniazid
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Christine KellyCente for Experimental Pathogen Host Research (CEPHR), University College Dublin, Dublin, Ireland.ORCID 0000-0002-3239-7714
Willard TinagoCente for Experimental Pathogen Host Research (CEPHR), University College Dublin, Dublin, Ireland.
Dagmar AlberInstitute of Child Health, University College London, London, United Kingdom.
Patricia HunterInstitute of Child Health, University College London, London, United Kingdom.
Natasha LuckhurstKingston University, London, United Kingdom.
Jake ConnollyKingston University, London, United Kingdom.
Francesca ArrigoniKingston University, London, United Kingdom.ORCID 0000-0001-8179-4700
Alejandro Garcia AbnerCente for Experimental Pathogen Host Research (CEPHR), University College Dublin, Dublin, Ireland.
Raphael Kamn'gonaMalawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi.
Irene ShehaMalawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi.
Mishek ChammudziMalawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi.
Kondwani JamboMalawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi.
Jane MallewaCollege of Medicine, University of Malawi, Blantyre, Malawi.
Alicja RapalaInstitute of Cardiovascular Science, University College London, London, United Kingdom.
Patrick W G MallonCente for Experimental Pathogen Host Research (CEPHR), University College Dublin, Dublin, Ireland.
Henry MwandumbaMalawi Liverpool Wellcome Trust Clinical Research Program, Blantyre, Malawi.
Nigel KleinInstitute of Child Health, University College London, London, United Kingdom.
Saye KhooInstitute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
University of Liverpool · GBUniversity College Dublin · IEUniversity College London · GBKingston University · GBUniversity of Malawi · MW

Funding

Wellcome TrustWellcome Trust 099934/Z/12/A
6 · The paper itself

Abstract

backgroundNon-communicable diseases (NCDs) are increased amongst people living with HIV (PLWH) and are driven by persistent immune activation. The role of socioeconomic status (SES) in immune activation amongst PLWH is unknown, especially in low-income sub-Saharan Africa (SSA), where such impacts may be particularly severe.

methodsWe recruited Malawian adults with CD4<100 cells/ul two weeks after starting ART in the REALITY trial (NCT01825031), as well as volunteers without HIV infection. Clinical assessment, socioeconomic evaluation, blood draw for immune activation markers and carotid femoral pulse wave velocity (cfPWV) were carried out at 2- and 42-weeks post-ART initiation. Socioeconomic risk factors for immune activation and arterial stiffness were assessed using linear regression models.

resultsOf 279 PLWH, the median (IQR) age was 36 (31-43) years and 122 (44%) were female. Activated CD8 T-cells increased from 70% amongst those with no education to 88% amongst those with a tertiary education (p = 0.002); and from 71% amongst those earning less than 10 USD/month to 87% amongst those earning between 100-150 USD/month (p = 0.0001). Arterial stiffness was also associated with higher SES (car ownership p = 0.003, television ownership p = 0.012 and electricity access p = 0.029). Conversely, intermediate monocytes were higher amongst those with no education compared to a tertiary education (12.6% versus 7.3%; p = 0.01) and trended towards being higher amongst those earning less than 10 USD/month compared to 100-150 USD/month (10.5% versus 8.0%; p = 0.08). Water kiosk use showed a protective association against T cell activation (p = 0.007), as well as endothelial damage (MIP1β, sICAM1 and sVCAM1 p = 0.047, 0.026 and 0.031 respectively).

conclusionsSocioeconomic risk factors for persistent inflammation amongst PLWH in SSA differ depending on the type of inflammatory pathway. Understanding these pathways and their socioeconomic drivers will help identify those at risk and target interventions for NCDs. Future studies assessing drivers of inflammation in HIV should include an SES assessment.

Indexed as

Social ClassAdultBiomarkersCarotid-Femoral Pulse Wave VelocityEducational StatusFamily CharacteristicsFemaleHIV InfectionsHumansIncomeInflammationMalawiMaleWaterBiomarkersWater

Identifiers

PMID34432828
PMCPMC8386842
OpenAlexW3035843512

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.